5-Azacitidine has limited therapeutic activity in myelofibrosis.
R A
RA
Mesa
S
S
Verstovsek
C
C
Rivera
A
A
Pardanani
K
K
Hussein
T
T
Lasho
W
W
Wu
A
A
Tefferi
D000368:Aged; D001374:Azacitidine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D017211:Treatment Failure; D016896:Treatment Outcome
D001374:Azacitidine